Emerging research suggest Retatru tide , a dual stimulator targeting both the gut-brain axis and glucose-dependent insulinotropic polypeptide , could provide a notable advancement for obesity treatment. Initial patient trials have indicated impressive reductions in abdominal tissue, conceivably outperforming current obesity therapies . Nevertheless